Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Werewolf Therapeutics, Inc. shareholders
As of Jun 30, 2026, 44 institutions reported holding Werewolf Therapeutics, Inc., 22.4% of its shares. Largest: Ra Capital Management, L.P., Balyasny Asset Management L.P. and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Werewolf Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 2.39M | 4.9% | −4.29M | Aug 14, 2026 |
| Balyasny Asset Management L.P. | 1.79M | 3.7% | new | Aug 14, 2026 |
| Vanguard | 1.38M | 2.8% | no change | Aug 13, 2026 |
| Renaissance Technologies | 675K | 1.4% | +158K | Aug 13, 2026 |
| Lynx1 Capital Management LP | 658K | 1.4% | no change | Aug 13, 2026 |
| Sphera Funds Management LTD. | 627K | 1.3% | no change | Aug 14, 2026 |
| DC Funds, LP | 589K | 1.2% | no change | Aug 14, 2026 |
| Verdad Advisers, LP | 349K | 0.72% | +319K | Aug 14, 2026 |
| Geode Capital | 336K | 0.69% | −53,672 | Aug 12, 2026 |
| Bank of America | 312K | 0.64% | +46,919 | Aug 14, 2026 |